Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients after cyclosporin-treated corneal grafting.
Allograft rejection occurs in up to 70% of high-risk keratoplasty patients. For this reason short-term Cyclosporin treatment was administered for three months to prevent graft loss. Of 23 renal healthy patients, 19 enjoyed long-term graft acceptance. We evaluated in these patients N-acetyl-beta-D-glucosaminidase (NAG) excretion as a marker of renal tubular damage. All patients, except one, showed urinary NAG excretion to be within the normal range. From this we conclude that no renal tubular damage occurs after short-term Cyclosporin treatment.
Kieselbach
F
F
Universitätsklinik für Augenheilkunde, Universität Innsbruck, Osterreich.
Kotanko
P
P
D000118:Acetylglucosaminidase / Q000652:urine*; D016039:Corneal Transplantation; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D007684:Kidney Tubules / Q000187:drug effects; D014184:Transplantation, Homologous
D003524:Cyclosporins; D000118:Acetylglucosaminidase